| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/30/2010 | US20100248364 SENSE OLOGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 09/30/2010 | US20100248363 Matrices and media for storage and stabilization of biomolecules |
| 09/30/2010 | US20100248362 Multi channel, flow cytometry units; computer controlled fluid flow, laser analysis; sorting X and Y sperm cells |
| 09/30/2010 | US20100248361 Platelet production methods |
| 09/30/2010 | US20100248360 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 09/30/2010 | US20100248359 Anti-Glypican 3 Antibody |
| 09/30/2010 | US20100248358 Cell separating apparatus and cell separating method |
| 09/30/2010 | US20100248357 Nematode Fatty Acid Desaturase-Like Sequences |
| 09/30/2010 | US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 09/30/2010 | US20100248305 Polyamino acid synthetase and gene encoding the same |
| 09/30/2010 | US20100248304 Dual expression vector system and screening methods |
| 09/30/2010 | US20100248291 Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof |
| 09/30/2010 | US20100248285 Method And Apparatus For The Processing And/Or Analysis And/Or Selection Of Particles, In Particular Biological Particles |
| 09/30/2010 | US20100248274 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 09/30/2010 | US20100248262 Anti-Fibronectin Fragment Monoclonal Antibody |
| 09/30/2010 | US20100248255 Novel peptides |
| 09/30/2010 | US20100248240 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 09/30/2010 | US20100248229 Invitro human embryonic model and a method thereof |
| 09/30/2010 | US20100248211 Method for analysis of hepatitis b virus s antigen |
| 09/30/2010 | US20100248207 Separation method of biological objects relative to their viscoelastic properties |
| 09/30/2010 | US20100248206 Method of Isolating Stem and Progenitor Cells From Placenta |
| 09/30/2010 | US20100248205 Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions |
| 09/30/2010 | US20100247733 Plants and seeds of corn variety cv006790 |
| 09/30/2010 | US20100247621 Codon modified immunogenic compositions and methods of use |
| 09/30/2010 | US20100247602 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 09/30/2010 | US20100247601 Repair and treatment of bone defect using cells induced by agent produced by chondrocytes capable of hypertrophication and scaffold |
| 09/30/2010 | US20100247579 Therapeutic agent for cancer |
| 09/30/2010 | US20100247577 Tr1 cells, mesenchymal stem cells and uses thereof |
| 09/30/2010 | US20100247565 Chimeric sindbis-eastern equine encephalitis virus and uses thereof |
| 09/30/2010 | US20100247560 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof |
| 09/30/2010 | US20100247556 Method for activation of helper t cell and composition for use in the method |
| 09/30/2010 | US20100247553 Goodpasture Antigen Binding Protein |
| 09/30/2010 | US20100247549 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 09/30/2010 | US20100247547 Modulation of the th-17 cell mediated immune responses |
| 09/30/2010 | US20100247546 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/30/2010 | US20100247545 Antibodies to m-csf |
| 09/30/2010 | US20100247542 Truncated variant of the mammalian target for rapamycin (mtor) protein |
| 09/30/2010 | US20100247531 Anti-fgfr3 antibodies and methods using same |
| 09/30/2010 | US20100247527 Composition and method for treatment of autoimmune disease |
| 09/30/2010 | US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/30/2010 | US20100247516 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 09/30/2010 | US20100247502 Tumor/b-cell hybrid cells and uses thereof |
| 09/30/2010 | US20100247498 In vitro micro-organs, and uses related thereto |
| 09/30/2010 | US20100247494 Compositions of Mesenchymal Stem Cells to Regenerate Bone |
| 09/30/2010 | US20100247493 Method for Identifying and Selecting Cardiomyocytes |
| 09/30/2010 | US20100247490 SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38 |
| 09/30/2010 | US20100247486 Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same |
| 09/30/2010 | US20100247461 Anti-inflammatory complexes |
| 09/30/2010 | US20100247442 Macaca fascicularis ST2L |
| 09/30/2010 | US20100247430 Methods and Compositions for Modulating T Cells |
| 09/30/2010 | DE102008033570B4 Verfahren zur Zellidentifikation und Zellsortierung A method for cell identification and cell sorting |
| 09/30/2010 | CA2793276A1 Ganglioside biosynthesis modulators |
| 09/30/2010 | CA2756743A1 Novel receptor hetero-dimers/-oligomers |
| 09/30/2010 | CA2756670A1 Mesenchymal stem cells producing inhibitory rna for disease modification |
| 09/30/2010 | CA2756600A1 Human umbilical cord tissue cells as therapy for alzheimer's disease |
| 09/30/2010 | CA2756594A1 Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
| 09/30/2010 | CA2756168A1 Isoform nell-1 peptide |
| 09/30/2010 | CA2755983A1 Compounds and methods for modulating an immune response |
| 09/30/2010 | CA2755387A1 Novel lysophospholipid acyltransferase |
| 09/30/2010 | CA2754610A1 Tumor-initiating cells and methods for using same |
| 09/30/2010 | CA2753388A1 Compounds compositions and methods of treating cancer and fibrotic diseases |
| 09/29/2010 | EP2233574A1 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/29/2010 | EP2233567A1 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| 09/29/2010 | EP2233566A1 Generation of pancreatic progenitor cells |
| 09/29/2010 | EP2233565A1 Medium for mammalian somatic cells and additive therefor |
| 09/29/2010 | EP2233564A2 Cell culture sheet comprising a functional substrate with a group of columnar micro-pillars and its manufacturing method |
| 09/29/2010 | EP2233561A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 09/29/2010 | EP2233494A1 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 09/29/2010 | EP2233150A2 Erythropoietin for use in the treatment of wounds or the transplantation of cells |
| 09/29/2010 | EP2231708A1 Remedies for pemphigus containing anti fas ligand antobodies |
| 09/29/2010 | EP1929034B1 Cancerous disease modifying antibodies |
| 09/29/2010 | EP1907532B1 Biological materials and uses thereof |
| 09/29/2010 | EP1729803B1 Therapeutic use of anti-cs1 antibodies |
| 09/29/2010 | EP1617852B1 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration |
| 09/29/2010 | EP1223956B1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 09/29/2010 | EP1105469B1 Mammalian transgenesis by intracytoplasmic sperm injection |
| 09/29/2010 | CN1932024B Taxol biosynthesizing process and special culture medium |
| 09/29/2010 | CN1878785B Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
| 09/29/2010 | CN1470633B Totipotent somatic cell |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101849002A Method for maintaining foreign gene in cell stably |
| 09/29/2010 | CN101849000A Reductase, gene thereof and method of using the same |
| 09/29/2010 | CN101848999A Anti-CD20 monoclonal antibodies |
| 09/29/2010 | CN101848994A Method of efficiently establishing induced pluripotent stem cells |
| 09/29/2010 | CN101848993A Method for differentiating embryonic stem cells into cells expressing AQP-1 |
| 09/29/2010 | CN101848992A Use of the opposite cell differentiation program (OCDP) for the treatment of degenerated organs in the pathological state |
| 09/29/2010 | CN101848991A Isolated cell mass |
| 09/29/2010 | CN101848990A Compositions and methods for the modification of physiological responses in plants |
| 09/29/2010 | CN101848925A Biologically active C-terminal arginine-containing peptides |
| 09/29/2010 | CN101848738A Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery |
| 09/29/2010 | CN101848718A Cell composition for tissue regeneration |
| 09/29/2010 | CN101845447A Beta-agarase encoding gene and gene acquisition method |
| 09/29/2010 | CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/29/2010 | CN101845437A Promoter with properties of inducing and organizing specific expression |
| 09/29/2010 | CN101845427A Halophilic cellulase, encoding gene thereof and application thereof |
| 09/29/2010 | CN101845426A Odontotermes formosanus beta-glucosidase, coding gene, vector and application thereof |
| 09/29/2010 | CN101845425A Alpha-galactosidase and expression and purification method thereof |
| 09/29/2010 | CN101845421A Wild soybean salt resistant protein kinase GsCBRLK and coding gene and application thereof |
| 09/29/2010 | CN101845417A Cell sorting method by using avidin/streptavidin magnetic composite particles |
| 09/29/2010 | CN101845416A Adipose-derived stem cell for senile dementia treatment |